Back to Search
NOUR SNEIGE, M.D.
M.D.
Cytopathology Physician
NPI: 1467558288IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cytopathology PhysicianPrimary
Pathology — Cytopathology
Code: 207ZC0500X
G1203(TX)
CMS Specialties
PrimaryPATHOLOGY
Education
OTHER
Class of 1972
Research & Publications (20)
Correlation of cytologic findings and chromosomal instability detected by fluorescence in situ hybridization in breast fine-needle aspiration specimens from women at high risk for breast cancer.
PMID 16528376·Mod Pathol·2006
8-other
Utility of cytologic specimens in the evaluation of prognostic and predictive factors of breast cancer: current issues and future directions.
PMID 14986295·Diagn Cytopathol·2004
6-review
Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast microcalcifications. Considerations for surgical excision.
PMID 12579995·Am J Clin Pathol·2003
8-other
Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases.
PMID 12379750·Mod Pathol·2002
8-other
Low-grade (fibromatosis-like) spindle cell carcinoma of the breast.
PMID 11474284·Am J Surg Pathol·2001
8-other
Chemotherapy-induced histologic changes in mastectomy specimens and their potential significance.
PMID 14965629·Breast·2001
8-other
Fine-needle aspiration cytology of in situ epithelial cell proliferation in the breast.
PMID 11993709·Am J Clin Pathol·2000
6-review
Accuracy of cytologic diagnoses made from touch imprints of image-guided needle biopsy specimens of nonpalpable breast abnormalities.
PMID 10907929·Diagn Cytopathol·2000
8-other
Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.
PMID 19605817·Am J Clin Pathol·2009
4-observational
Immunohistochemical characterization of subtypes of male breast carcinoma.
PMID 19442295·Breast Cancer Res·2009
8-other
Implementation of American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Recommendations in a tertiary care facility increases HER2 immunohistochemistry and fluorescence in situ hybridization concordance and decreases the number of inconclusive cases.
PMID 19415952·Arch Pathol Lab Med·2009
4-observational
Chromogenic in situ hybridization is a reliable method for detecting HER2 gene status in breast cancer: a multicenter study using conventional scoring criteria and the new ASCO/CAP recommendations.
PMID 19289584·Am J Clin Pathol·2009
4-observational
Human papillomavirus genotyping for the eight oncogenic types can improve specificity of HPV testing in women with mildly abnormal Pap results.
PMID 18500260·Mod Pathol·2008
4-observational
Neovascularization in mucinous ductal carcinoma in situ suggests an alternative pathway for invasion.
PMID 18983463·Histopathology·2008
8-other
Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma.
PMID 17977987·J Clin Microbiol·2008
4-observational
Metastases to intramammary lymph nodes in patients with breast cancer: sonographic findings.
PMID 18366093·J Clin Ultrasound·2008
4-observational
Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
PMID 18300793·Am J Surg Pathol·2008
4-observational
Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas.
PMID 18059234·Am J Surg Pathol·2007
4-observational
Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice.
PMID 18049131·Adv Anat Pathol·2007
6-review
Imaging differences in metaplastic and invasive ductal carcinomas of the breast.
PMID 18029860·AJR Am J Roentgenol·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1467558288
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 54
- Publications
- 20
Are you this provider?
Claim Your Profile